implant placements in knees and reduces pain. The trial is comparing Mako's Restoris implant using the firm's robotic arm with the manual placement of the Oxford Partial Knee implant from Biomet Orthopedics. ( PR ) Post your comment!
results were incrementally encouraging. Revenue rose more than 5% this quarter, with organic growth of nearly 6%. Like Biomet and Johnson & Johnson ( JNJ ), Stryker benefited from a recovery in the recon space, as revenue rose more than 6% on
12 - Standard & Poor's Ratings Services said today that its ratings on Warsaw, Ind.-based medical products manufacturer Biomet Inc. are not affected by the company's intention to add on $250 million of debt to its existing extended term loan due July
Sept. 18 - Standard & Poor's Ratings Services said today that it assigned Warsaw, Ind.-based medical products manufacturer Biomet Inc.'s $500 million senior subordinated notes maturing 2020 its 'B-'...
Sept 18 (Reuters) - Biomet Inc : * Moody's assigns b3 to biomet 's add-on sr. notes and caa1 to sr. sub notes * Rpt-moody's assigns b3 to biomet 's add-on sr. notes and caa1 to sr. sub notes
Management made it clear, though, that it would continue evaluating acquisition opportunities. While we think a merger with Biomet remains a compelling option, management previously has expressed an interested in bolt-on acquisitions that would enhance
July 25 (Reuters) - Biomet Inc. on Wednesday sold $1 billion of senior notes in the 144a private ..... Fargo were the joint bookrunning managers for the sale. BORROWER: BIOMET AMT $1 BLN COUPON 6.5 PCT MATURITY 08/01/2020 TYPE SR NTS ISS
July 25 (Reuters) - Moody's assigns B1 to Biomet 's amended bank facilities and B3 to senior unsecured notes, affirms B2 corporate family rating
that it assigned its 'B-' issue-level and '6' recovery ratings to Warsaw, Ind.-based medical products manufacturer Biomet Inc.'s proposed $550 million senior unsecured notes maturing 2020. The recovery rating reflects our expectation for negligible
Overview -- Warsaw, Ind.-based medical products manufacturer Biomet Inc. plans to refinance its existing cash flow revolver, and amend and extend a portion of its term debt. -- We are...